Jill Carroll
CIK 1598542 · last filed 2026-05-01
Jill Carroll is a corporate insider who has filed 12 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for AVLN, was dated May 1, 2026. Across all open-market trades the lifetime net is −$66.8M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
12
-$66.80M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVLN | Director | 1,908,784 | — | — | $5.00M | 1 | 2026-05-01 |
| Arcellx, Inc. (ACLX) Delisted | Director | 0 | $115.07 | $0 | -$78.30M | 9 | 2026-04-28 |
| Pandion Therapeutics, Inc. (PAND) Delisted | Director | 0 | $60.05 | $0 | $6.50M | 2 | 2021-04-01 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-01 | AVLN | Mixed | +2,186,562 | $5.00M | EDGAR |
| 2026-04-28 | Arcellx, Inc. (ACLX) Delisted | Mixed | −1,479,148 | $0 | EDGAR |
| 2025-05-30 | Arcellx, Inc. (ACLX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-06 | Arcellx, Inc. (ACLX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-25 | Arcellx, Inc. (ACLX) Delisted | Sell (S) | −504,263 | -$35.58M | EDGAR |
| 2023-12-18 | Arcellx, Inc. (ACLX) Delisted | Sell (S) | −504,263 | -$24.77M | EDGAR |
| 2023-06-16 | Arcellx, Inc. (ACLX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-02 | Arcellx, Inc. (ACLX) Delisted | Sell (S) | −340,720 | -$14.21M | EDGAR |
| 2023-05-15 | Arcellx, Inc. (ACLX) Delisted | Sell (S) | −638,417 | -$28.74M | EDGAR |
| 2022-02-09 | Arcellx, Inc. (ACLX) Delisted | Mixed | +5,500,007 | $25.00M | EDGAR |